Abstract Guidelines

All abstracts must be submitted via this website by clicking on the button below “Submit an Abstract Today”. Refer to the deadline table above.

• Authors may be the main author on a maximum of TWO (2) abstracts.
• Authors may be the presenting author on a maximum of TWO (2) abstracts.
• Authors may be a co-author on any number of abstracts.
• The Submitting Author is required to ensure that all co-authors are aware of the content of the abstract before submitting.
• Upon submission, the submitting author confirms that the abstract has been proofread and that all information is correct.
• Changes to the abstract can be made until the submission deadline. The submitting/corresponding author accepts that the content of the abstract cannot be modified or corrected after final submission and that it will be published exactly as submitted.
• The presenting author can be changed until the Early Bird Registration Deadline.
• All presenting authors must also complete the Presenting Author Survey and upload a completed Conflict of Interest Form with this survey by the Early Bird Deadline.
• The presenting author must attend in-person to present (virtual options will not be available).
• All accepted abstracts must have at least ONE (1) co-author (usually this is the presenting author) who is registered and who has paid the registration fees to attend the MASCC/JASCC/ISOO 2023 Annual Meeting by the Early Bird Deadline (Wednesday, April 19, 2023) to be included in the Scientific Program and published in the journal Supportive Cancer Care.
• All presenting authors must be registered and paid the registration fees for the MASCC/JASCC/ISOO 2023 Annual Meeting.

• All abstracts must be submitted in English. All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility), or by a copy editor, prior to submission.
• The abstract title is limited to 150 characters including spaces.
• The abstract title must be entered in UPPER CASE (e.g. “COMMON BLEEDING DISORDERS”).
• The abstract text is limited to 300 words. The submission platform will show you a live word count at the bottom of the page, but it will not stop you from typing if you exceed the word limit. It is the responsibility of the submitting author to ensure that you do not exceed the word limit.
• The following structure must be followed when submitting an abstract:
  • Introduction
  • Methods
  • Results
  • Conclusions
• Each abstract can contain up to THREE (3) images or tables. To include a table, you will prepare the table in another application and take a screenshot of the table to include it as an image in the submission.
• Abstracts containing previously presented data are eligible for submission. However, inclusion of updated data is encouraged.

• The following details for EACH co-author, including the submitting author is required:
  • Full first and family name(s)
  • Preferred title (e.g. “Dr.”, “Prof”, “Assoc Prof”, etc.)
  • Designations (e.g. “PhD”, “DDS”, “MD”, etc.)
  • Affiliations including the department, institution/hospital, city, state (if relevant), and country (e.g. “Department of Psychology, University of Tokyo, Tokyo, Japan”)
• Keywords for the abstract
• Abstract Topic (see the list below)
• The preferred presentation type:
  • e-Poster Presentation (5 minutes, presented in the Exhibition)
  • Oral Proffered Paper (10 minutes, presented during a Parallel Session)
• If you are applying for an award and/or scholarship, please ensure you also have the following information prepared:
  • Your degree, including year commenced and year completed (or will completed)
  • Information about any funding available to you
  • IMPORTANT: Abstracts applying for a Conference Scholarship are due before the regular deadline on Wednesday, December 21, 2022.
• Presenting authors must complete the Presenting Author Survey and upload a completed Conflict of Interest Form with this survey by the Early Bird Deadline.

All abstracts must be relevant to supportive care in cancer. This year’s topics include:

• Antiemetics
• Bone & Musculoskeletal
• Cancer Pain
• COVID-19
• Digital Health
• Education
• Exercise Oncology
• Fatigue
• Geriatrics
• Hemostasis
• Immuno-Oncology
• Mucositis
• Neurological Complications
• Neutropenia, Infection and Myelosuppression
• Nutrition and Cachexia
• Oncodermatology
• Oral Care
• Palliative Care
• Pediatrics
• Psychosocial
• Robotics & Artificial Intelligence
• Supportive Care in Hematology
• Survivorship
• Traditional Medicine
• Other

Abstracts will be reviewed with four (4) major criteria in mind:

1. Impact – Significance of the science in improving care
2. Innovation – Novelty
3. Approach – Study design, sample size, rigidity of research
4. Presentation – Clarity, logic, completeness of data presented

Late-breaker abstracts will also be evaluated on meeting the “late-breaker” criteria: Original research that is not completed until after the regular submission deadline. The content must meet criteria for urgency and significant scientific importance to be considered in this category.

Keeping these above domains in mind, each abstract will be graded on a scale of 1-10 per the guidelines outlined below:

   1-2 = Extremely poor (rejection warranted)
   3-4 = Substandard (revisions needed)
   5-7 = Good (consideration for an e-poster presentation)
   8-9= Excellent (consideration for an oral proffered paper)
   10 = Exceptional (the reviewer believes this must be an oral proffered paper)